IDH2 and central nervous system cancer: (24, 25) IDH assessment can distinguish diffuse gliomas with IDH mutations from glioblastoma, IDH-wildtype and other types of IDH-wildtype gliomas, including diffuse midline glioma, H3 K27-altered, and diffuse hemispheric glioma, H3 G34-mutant.